APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$4.81
-1.94% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-87.27
Dividend yield
—
52W range
$4 – $189
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $119.97M | $112.46M | $91.86M | $117.01M | $67.49M | $53.41M | $53.55M | $56.60M | $34.22M | $24.84M | $15.59M |
| Cash & equivalents | — | $3.59M | $4.64M | $9.68M | $7.09M | $30.64M | $12.45M | $39.98M | $45.04M | $22.64M | $16.90M | $8.71M |
| Current assets | — | $41.55M | $35.13M | $71.41M | $95.08M | $48.69M | $30.00M | $47.26M | $52.57M | $27.45M | $19.07M | $10.66M |
| Total liabilities | — | $25.36M | $23.84M | $41.29M | $34.97M | $37.09M | $41.57M | $36.95M | $55.38M | $16.24M | $12.62M | $10.84M |
| Current liabilities | — | $19.84M | $19.94M | $19.54M | $18.51M | $17.61M | $38.24M | $14.54M | $34.76M | $8.71M | $7.22M | $6.21M |
| Long-term debt | — | — | — | $18.38M | $15.73M | $19.28M | — | $20.05M | $3.71M | $1.46M | — | — |
| Shareholder equity | — | $94.61M | $88.62M | $50.57M | $82.03M | $30.41M | $11.84M | $16.59M | $1.22M | $17.97M | $12.22M | $4.75M |
| Retained earnings | — | $-172.67M | $-231.99M | $-80.69M | $-73.72M | $-127.41M | $-167.86M | $-185.61M | $-214.06M | $-206.04M | $-223.45M | $-247.58M |
| Accounts receivable | — | $15.13M | $7.83M | $4.28M | $2.14M | $5.22M | $7.02M | $2.37M | $3.66M | $2.50M | — | — |
| Inventory | — | $17.63M | $20.32M | $6.64M | $1.03M | $1.78M | $6.14M | $4.78M | $3.08M | $1.57M | — | — |
| Goodwill | — | $13.90M | $13.90M | $0.00 | $0.00 | — | — | — | — | — | — | — |